P
US8182844B2ActiveUtilityPatentIndex 31

Use of Clerodendrum sp. for treating tic disorders or psychiatric disorders with sensorimotor gating deficits

Assignee: CHIOU LIH-CHUPriority: Dec 31, 2009Filed: Jun 30, 2010Granted: May 22, 2012
Est. expiryDec 31, 2029(~3.5 yrs left)· nominal 20-yr term from priority
Inventors:CHIOU LIH-CHUFAN PI-CHUANHUANG WEI-JANWANG SU-JANE
A61K 36/855A61P 25/14A61P 25/18A61P 25/00
31
PatentIndex Score
0
Cited by
4
References
11
Claims

Abstract

The present invention relates to the use of a composition made from Clerodendrum for treating tic disorder or sensorimotor gating deficits, wherein the composition is particularly made from the leaves of the plant.

Claims

exact text as granted — not AI-modified
1. A method for treating tic disorders comprising administering to a subject in need thereof a composition comprising an effective amount of a  Clerodendrum inerme  extract. 
     
     
       2. The method of  claim 1 , wherein the extract comprises juice from  Clerodendrum inerme.    
     
     
       3. The method of  claim 1 , wherein the extract comprises leaf juice from  Clerodendrum inerme.    
     
     
       4. A method for treating psychiatric disorders with sensorimotor gating deficits comprising administering to a subject in need thereof a composition comprising an effective amount of a  Clerodendrum inerme  extract. 
     
     
       5. The method of  claim 4 , wherein the extract comprises juice from  Clerodendrum inerme.    
     
     
       6. The method of  claim 4 , wherein the extract comprises leaf juice from  Clerodendrum inerme.    
     
     
       7. The method of  claim 4 , wherein the extract is obtained from the leaves of  Clerodendrum inerme  by a solvent. 
     
     
       8. The method of  claim 7 , wherein the solvent is ethanol. 
     
     
       9. The method of  claim 4 , wherein the psychiatric disorders are schizophrenia, obsessive compulsive disorder (OCD), attention deficit hyperactivity disorder (ADHD), Tourette syndrome (TS), autism, or bipolar disorder. 
     
     
       10. The method of  claim 1 , wherein the composition is administered orally. 
     
     
       11. The method of  claim 4 , wherein the composition is administered orally.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.